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SUMMARY
Although co-infection is the norm in most human and animal populations, clinicians currently have no practical tool to
assist them in choosing the best treatment strategy for such patients. Given the vast range of potential pathogens which
may co-infect the host, obtaining such a practical tool may seem an intractable problem. In ecology the joint concepts of
functional groups and guilds have been used to conceptually simplify complex ecosystems, in order to understand how their
component parts interact and may be manipulated. Here we propose a mechanism by which to apply these concepts to
pathogen co-infection systems. Further, we describe how these groups could be incorporated into a mathematical mod-
elling framework which, after validation, could be used as a clinical tool to predict the outcome of any particular combi-
nation of pathogens co-infecting a host.
Key words: Functional groups, guilds, co-infection, mixed infection, pathogens, modelling.
THE IMPORTANCE OF CO-INFECTION
For the majority of human and animal populations
worldwide, infectious disease is not the result of
a single pathogen, but the consequences of mul-
tiple pathogens infecting the host simultaneously
(Christensen et al. 1987). Even in cases where current
infection is the result of a single pathogen species,
prior history of infection may be important in de-
termining the outcome of current infection (Walzl
et al. 2000).
Despite the fact that co-infection can inﬂuence the
clinical outcome of disease, there is little information
in the literature, with the possible exception of con-
current infections with HIV (Harms and Feldmeier,
2002; Kontorinis, Agarwal and Dieterich, 2005;
Rockstroh, 2006; Sullivan et al. 2006), as to the
consequences of particular pathogen co-infection
combinations. This paucity of data leaves the clin-
ician without a clear idea of how any particular
combination of infectious agents may alter the course
of disease or the eﬃcacy of any treatment regime.
Even where clinicians do realise the potential prob-
lems caused by co-infection, they have little choice
but to treat the various pathogen species as if each
were infecting the host singly. Such decisions are
inevitable given that most pathogen control strat-
egies have been extended from laboratory studies, in
which hosts are infected with only one pathogen at
time. No current mechanism exists by which clin-
icians can make informed decisions about best
practice when presented with a co-infected patient.
Nevertheless, it is becoming increasingly clear, from
both theoretical and clinical studies, that treating co-
infected patients as if they were infected with a series
of isolated pathogen species is insuﬃcient and may
lead to ineﬀective disease control or even to increased
damage to the host (Lello et al. 2004; Brown et al.
2005).
Co-infection has consequences for both the host
and the pathogen species involved. For example,
concurrent or prior infection may increase pathogen
virulence and this in turn could lead to increased
disease severity (Graham et al. 2005; Abu-Raddad,
Patnaik and Kublin, 2006; Deka et al. 2006; Hughes
and Shafran, 2006; Page, Scott and Manabe, 2006).
Recent studies have highlighted how the severity
of the disease caused by one organism may be
altered by the presence of a second species. For ex-
ample, infection with Hepatitis C has been reported
to increase the incidence of AIDS deﬁning events
in HIV infected patients (Stebbing et al. 2005).
Similarly, chickens co-infected with crypto-
sporidium and Marek’s Disease show increased se-
verity of both diseases when compared to singly
infected individuals (Abbassi et al. 2000). However,
it should be noted that not all co-infection leads to
increased severity of disease. Indeed, in some cases
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co-infection may lead to decreased disease severity.
For example, one study shows that infection with
rotavirus is less severe if the host is concurrently
infected with Giardia lamblia (Bilenko et al. 2004).
Similarly, inﬂuenza-induced pathology in mice is
ameliorated by co-infection with Trichinella spiralis
(Furze, Hussell and Selkirk, 2006). In these latter
two cases, it may be advisable to hold back on
treatment of one species (in these cases G. lamblia
and T. spiralis) until after the more damaging in-
fection has been cleared, rather than attempting to
treat both diseases simultaneously. Without a clear
understanding of the dynamics of the whole system,
such delayed treatment might have other unforeseen
consequences.
The duration of the disease may also be altered by
co-infection (Walzl et al. 2000) and extended infec-
tions may be due to increased survival or fecundity of
the parasite or to a reduced capacity of the host to
resist or eliminate the infection(s). Whatever the
cause, increased disease duration can mean a longer
period of infectiousness for the patient (and hence
transmission opportunities for the pathogens) and
may also lead to increased disease severity, simply
because the host accumulates damage over a longer
period.
Finally, both treatment eﬃcacy and the degree to
which the treatment itself harms the patient may be
aﬀected by co-infection. For example, a recent study
has shown that treatment for schistosomiasis causes
an increase in HIV viral load in co-infected in-
dividuals (Brown et al. 2005). Further, co-infection
may buﬀer pathogen species from the eﬀects of a
treatment strategy, or could favour one pathogen
over another (thus producing an apparent compe-
tition and potentially changing the aetiology of
the disease). Where competition between pathogen
species has resulted in a more virulent species being
suppressed, targeted control of the competitor could
release the virulent species from its constraints and
the host may suﬀer a more severe disease than if the
treatment had not occurred (Lello et al. 2004).
There is undoubtedly a growing comprehension of
the importance of co-infection, which may be seen in
the rapid increase in the percentage of publications in
which the words, co-infection or mixed infection are
found within the title (Fig. 1). Currently, only prior
knowledge of the consequences of particular combi-
nations of pathogens can provide the clinician with
any solid decision-making tool and there are very few
published examples of such co-infection data. Why
then has no mechanism been developed to aid clin-
icians in dealing with co-infected patients? We be-
lieve that the reason is that the problem is viewed as
intractable, given the virtually inﬁnite number of
possible combinations of pathogens with which hu-
man and animal hosts may be infected. In order to
provide clinicians with a tool with which they could
deal with any potential co-infection combination,
some simpliﬁcation mechanism must be found. In
this review we present one possible mechanism for
simpliﬁcation. It is important to be clear that we are
not proposing this mechanism as the only potential
simpliﬁcation that could be undertaken, nor will
we present a ﬁnished product, but rather we describe
one possible method for achieving this aim.
PATHOGEN INTERACTION THROUGH IMMUNITY
Every pathogenwill have some degree of eﬀect on the
immune system of the host, stimulating or suppres-
sing particular pathways of the immune response.
These various pathways are interlinked through up-
and down-regulatorymechanisms. Therefore, unless
the immune response against a pathogen is entirely
localised and the pathogens involved in the co-
infection are spatially separated, we should expect
that one organism would usually have an eﬀect upon
another when co-infecting a host. For example, in
humans, there is a known see-saw response between
the Th1 and Th2 branches of the immune response,
such that an increase in the Th1 response generally
results in a lower Th2 response and vice versa (Diehl
and Rincon, 2002). Page et al. (2006) discuss the
eﬀects of a strongly Th2-inducing infection with
the mouse nematode, Heligmosomoides polygyrus, on
the host response to a subsequent infection with the
bacterium Helicobacter felis. The helminth infection
is associated with a down-regulation of the Th1 re-
sponse against the bacterium. In this case the path-
ology of the disease is largely immune mediated and
hence this down-regulation could be interpreted as a
positive outcome. Conversely if a Th1-inducing or-
ganism such as T. gondii infects the host ﬁrst, then
the Th1-induced damage increases.
It should be noted that direct interactions between
pathogen species are also possible, but even less
documentation may be found on the consequences of
these co-infections. Further, it is generally more
diﬃcult to establish the mechanism for direct
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Fig. 1. Increase in the percentage of publications
containing the terms ‘co-infection’ or ‘mixed infection’
in the title, as calculated from a Web of Science1 search
between 1970 and 2008.
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pathogen interactions, as the tools with which they
could be elucidated have not been developed to the
same extent as immunological parameter assess-
ments. Co-infecting pathogens are often separated
into diﬀerent physical niches within the host, either
in diﬀerent tissues and organs or in diﬀerent cellular
compartments (e.g. outside of host cells, free within
the cytoplasm or in vesicles within the cytoplasm)
and direct interactions are less likely to occur in such
cases. Therefore, we believe that direct interactions
are likely to make up a smaller subset of the overall
potential co-infection mechanisms, although this is
open for debate. Whatever the overall importance of
such non-immune-mediated interactions, because of
the lack of available data on this topic we will not
consider them further. Nevertheless, in the limited
number of pathogen systems where such information
is available, there is no reason that they could not be
included in the overall framework described here-
after.
FUNCTIONAL/GUILD GROUPINGS: A MECHANISM
FOR SIMPLIFICATION
Well-established concepts in ecology are the func-
tional group and the guild (Catovsky, 1998; Blondel,
2003; Davic, 2003; Biber, Harwell and Cropper,
2004; Davis et al. 2004; Dumay et al. 2004; Wardle
and Zackrisson, 2005; Petchey and Gaston, 2006;
Storkey, 2006; Pedersen and Fenton, 2007). The two
terms are often used synonymously and may indeed
deﬁne the same groups under certain circumstances.
However, in a review of the topic by Blondel (2003)
the two terms are considered as separate, with the
functional groups being associated with ‘eﬀects’
upon the ecosystem (functions they perform) and
guilds being deﬁned by resource use or ‘response’ to
the ecosystem. Of course, any particular organism
may be categorised either into a functional group or a
guild, and it would be possible to create a new group
deﬁnition which combines both functional group and
guild concepts. Functional groups and guilds may
contain taxonomically related species but can also
cross such taxonomic boundaries (Blondel, 2003;
Hood et al. 2006). For example, the broad functional
group ‘decomposers’ may include bacteria, fungi
and soil animals such as earthworms and collembo-
lans (Milcu et al. 2006). Similarly, the oceanic
functional group termed calciﬁers includes phyto-
plankton, zooplankton and reef-building coral
species (Hood et al. 2006). There has been wide de-
bate about the deﬁnition and usefulness of functional
groups and guilds, and it is possible for the same
organism to be placed into entirely diﬀerent group-
ings (under either term) based upon the criteria used
to deﬁne the groups (Petchey and Gaston, 2006).
Obviously, the usefulness of this group approach to
conceptually simplifying complex ecosystems is only
as good as the accuracy of the group deﬁnitions. The
best examples of using such groupings eﬀectively are
those where the groups are deﬁned in association
with the question being investigated. For example, if
the question relates to nutrient cycling, then the
deﬁnition of the functional groups must be directly
related to an organism’s place in this process (Hood
et al. 2006; Petchey and Gaston, 2006). Any par-
ticular organism might have a diﬀerent grouping if
the question being examined was related to some
other aspect of its environmental activity or response,
e.g. trophic level. Similarly, organisms may shift
between groups at diﬀerent stages of their life cycle
(Blondel, 2003) and the groupings should be seen as
dynamic. If the groups are clearly deﬁned then the
relationships between them are also clear and pre-
dictable e.g. primary producers ﬁx energy from the
sun, or other sources, and provide food for the ﬁrst
trophic level of consumers.
One advantage to creating functional groups is that
any novel organism’s inﬂuence upon its ecosystem
may be predicted by assigning that organism to one
of the deﬁned functional groups, based on some
typical group characteristics (King, Andersen and
Cutter, 1998; Storkey, 2006). Plant ecologists have
made particularly good use of this concept in a
number of studies, where plant functional groups are
deﬁned based upon combinations of easily measured
characteristics such as leaf thickness or tree height
(Foster and Brooks, 2005; Poorter, Bongers and
Bongers, 2006).
Ecosystem models, using functional groups, have
proven highly eﬀective as methods to understand the
mechanics of ecosystems and to predict the outcomes
of perturbations to those systems (Biber et al. 2004;
Dumay et al. 2004; Storkey, 2006). Fulton et al.
(2004) describe the simpliﬁcation of a very complex
Integrated Bay Ecosystem Model (IGBEM) by use
of functional groups. The resulting Bay Model 2
(BM2) agreed well with the more complex model in
its capacity to predict a range of features from pre-
dicted biomass through to community composition
of the benthos, and, in fact, was a better predictor of
this latter feature. As the functional groups alone are
clearly accurate predictors of the system, this guides
understanding of what the key processes are within
that system. Biber et al. (2004) describe the use of a
functional group model of macro-algae within a
seagrass habitat in South Florida which they use to
predict annual biomass dynamics. They validated
the model with real data and then used it to examine
the productivity responses under a range of stress
conditions imposed by freshwater discharges.
Although the model failed to predict responses in
canal-inﬂuenced conditions, it did very well under
sheet-ﬂow and oceanic conditions, and the failure in
the former case was thought to be due to a lack of data
on one of the functional groups. These examples
provide evidence of the potential usefulness of
functional group models and show that, where they
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fail, they are also useful in deﬁning what additional
information is required to improve their accuracy.
APPLYING THE FUNCTIONAL GROUP APPROACH
TO PATHOGENS
For a pathogen infecting a host, its ecosystem
consists of the components of the host biology and
immunology and of any other species of pathogen
with which the ﬁrst pathogen species may interact.
Importantly, any of these components of the eco-
system may be altered by the actions of the other
components. If we take a functional group guild
approach, with organisms deﬁned by their eﬀects
upon and responses to the ecosystem, then the usual
mechanism for grouping pathogens by taxa (e.g.
viruses, protozoa, bacteria, helminths) may not ap-
ply. We might ﬁnd that one functional group con-
tains a number of intracellular viruses, bacteria and
protozoa, all of which invade host cells and evade the
immune response for a time (Werling et al. 1998;
Carlyon and Fikrig, 2003; Shumilla et al. 2004).
Conversely, two helminth species might be placed in
diﬀerent functional categories because their eﬀects
on immune components are markedly diﬀerent
(Turner et al. 2003; Stadecker et al. 2004). However,
it is worth noting that functional groups and guilds
do often contain multiple organisms from the same
taxonomic grouping (Blondel, 2003).
There is little discussion in the literature regarding
the use of simplifying approaches to understanding
pathogen, in-host, ecosystems. Recently, Pedersen
and Fenton (2007) described a possible framework
by which pathogens might be assigned to guilds.
They suggest that guilds be deﬁned by shared
niche, which they further deﬁne by using three axes,
the resource axis (food), the location axis (infection
site(s)) and the immunological axis (i.e. which im-
mune components are stimulated). In adding the
third, immunological, axis the authors cross from a
resource use grouping (Blondel’s (2003) description
of a guild) and into a grouping concerned with the
functional role the pathogen plays in the ecosystem
(Blondel’s functional group). This approach is more
holistic and, as suggested earlier, a new categorisa-
tion term which includes both the functional group
and guild concept might be needed here. In the ab-
sence of such a new grouping term, and for sim-
plicity, we will refer hereafter to the term functional
group and drop the term guild.
An additional consideration in using an im-
munological axis for deﬁning pathogen groupings is
that it could be argued that stimulation of the im-
mune response is not a true function of the pathogen
but rather a function of the environment (the host)
acting against the pathogen. As such, some may ar-
gue that immune stimulation should not be used to
deﬁne the pathogens themselves. However, as many
pathogens are known to manipulate the host immune
system to their advantage and as the speciﬁc immune
response of the host would not exist without the
presence of the pathogen, the two are so inextricably
linked that we agree with Pedersen and Fenton
(2007) and believe that the host immune response
may legitimately be used as a grouping factor.
The response of the host to the presence of par-
ticular pathogens could be considered in terms of
Immunological Activity Groups (IAG). A Pathogen
Functional Group (PFG) which is deﬁned on the
basis of IAG, would have two components. If a
pathogen stimulates an inappropriate host immune
response (i.e. a response which does not lead to dis-
ease control and/or clearance) then it may have a
diﬀerent IAG for ongoing disease compared to a
controlled infection.
Application of a pathogen functional group con-
cept could be an extremely useful tool in exploring
the relationships between pathogens in concomitant
infections, provided that a suitable IAG can be cre-
ated. These IAGs are formed in same manner as
functional groups and as such must be chosen with a
clear question in mind. In this case, we wish to es-
tablish how the pathogens may interact through the
host immune system. Therefore, our deﬁnitions of
the groups should be driven by the potential forms of
immune stimulation that pathogens invoke and the
forms of immune response that the pathogens are
subsequently controlled by.
Much is known about the position of individual
immune components (at least those that are com-
monly recorded) in the various pathways of the im-
mune response and, in turn, the inter-relationships
of these pathways are also well understood.
Therefore, if functional groups are deﬁned on the
basis of the IAG, then prediction of the relationships
between these groups should also be possible.
Deﬁning pathogen functional groups should allow
assessment of both the likelihood of speciﬁc pathogen
interactions and the mechanisms by which those in-
teractions may be mediated. Furthermore, models
constructed using these groupings would allow the
dynamics of the pathogen infections and the conse-
quences of perturbations (e.g. treatment strategies)
to those dynamics to be predicted.
At the ﬁnest scale, the intricacies of how pathogens
interact with the host immune system are probably
as diverse as the species themselves. However, at a
median level of complexitymany parasite species will
share similar interaction mechanisms and it is at this
level that functional groupings could be useful. The
key to categorizing the functional groups is in de-
ﬁning the level of complexity at which the groupings
need to be set.
CREATING THE PFG MODEL
We propose that there should be ﬁve key stages to the
production of a clinically useful functional group
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model. First, a database should be constructed using
the current immunological literature on laboratory-
conducted, single-species infection experiments.
The database should contain the recorded immune
parameters for speciﬁc pathogen infections and,
where known, whether or not these immune re-
sponses were associated with successful pathogen
control (leading to cessation of infection) or with an
on-going infection (acute or chronic). Secondly, this
database would be used to form the IAG. Thirdly,
the Pathogen Functional Groups (PFG) would be
created. A PFGwould be deﬁned by two IAG scores,
one for the pathogen’s stimulatory eﬀects on the
immune system and one for the IAG by which the
pathogen is successfully controlled. The fourth step
in the process would be the model construction,
with the links between groups based upon the known
relationships between the IAG. The ﬁnal step is
validation and requires the model to be tested against
real co-infection data.
Suitable data do exist, at least for humans and
domestic animals, which would allow the construc-
tion of a database for the formation of the IAG.
However, such a process is a very large undertaking
and is beyond the scope of this review. Nevertheless,
here we demonstrate the potential to undertake this
process. We construct a small preliminary database
using a limited number of data ﬁelds and organisms
and use it to construct an example of an IAG. From
our example IAG we then form preliminary path-
ogen functional groups (PFG). The number of PFG
is simply the number of unique combinations of
the two IAG scores. Although this will potentially
lead to quite high numbers of PFG, the modelling
of these groups remains comparatively simple as
the IAG will always be fewer in number and it is the
IAG relationships that ultimately describe the
model.
It is important to stress that the database described
hereafter is not to be considered as anything more
than an example of how such a database may be
formed and the uses to which it can be put. Further,
the functional groups and example model produced
from those groups are also given solely as examples of
the proposed process and are not in any way intended
to be deﬁnitive, nor are we proposing that the model
described in this paper would be useful for clinical
purposes as it stands. What we hope to achieve is to
provide a framework by which researchers may
continue to explore this topic.
Step 1: Database production
To produce an example pathogen/immunological
database we preliminarily searched for the terms,
‘ interleukin, T-helper, Th1, Th2 and Th0’ in the
search engine Web of Science1. We then chose
fourteen of the infectious organisms (from the ﬁrst
few pages of the search) which yielded frequent hits
in this ﬁrst search (2 fungal, 3 helminth, 3 protozoan,
3 bacterial and 3 viral pathogens). Next, we con-
ducted a more detailed search on these organisms
using the species or genus name (as appropriate) and
a partial list of cytokines (i.e. IL-1, IL-2, IL-4, IL-5,
IL-6, IL-10, IL-12, IL-13, IFN-c and TNF-a).
Cytokine proﬁles were scored as having either no or
no recorded response (0), a down-regulation of that
response (x1), or an up-regulation of the response
(+1). Using only the cytokines described above ob-
viously constrained the database and we emphasise
that this was purely a constraint for the purposes
of this example.We also recorded the pathogen taxon
as either fungal, viral, bacterial, protozoan or hel-
minth.
For a full database we would recommend that
there be no a priori restrictions on which immune
features were recorded. All aspects of immune re-
sponse, including the cytokine proﬁles, information
on TLR stimulation (Liew et al. 2005), cellular im-
mune responses and genetic data could potentially be
useful. An extended database could also include
pathogen traits, such as infection site, the intra/
extracellular nature of the organism, its taxonomic
group, trophic level, virulence and relative growth
rates. Additionally, traits of the host could be in-
cluded where they may inﬂuence the immunological
outcome, e.g. species, host age and genetic infor-
mation such as mouse strain. If a damage component
is to be included in the model it would also be useful
to incorporate information as to the nature of the
pathogenesis of the disease, i.e. whether it is directly
pathogen mediated or caused via the actions of the
immune response. If these additional data are as-
sociated with particular immune activity groupings
with suﬃcient speciﬁcity, then these pathogen and
host traits could be used to assign novel organisms to
their speciﬁc IAG (and then their subsequent PFG)
without the need for direct measurement of the in-
dicator immune traits themselves.
Within our example database we divided the im-
munological proﬁles into those which were as-
sociated with ongoing disease and those which were
associated with disease control or cessation. Multiple
studies from diﬀerent authors (Table 5) were used
to make up the proﬁles for each disease and where
studies disagreed the majority ﬁnding was taken. For
a full database we would suggest that where a dis-
agreement is found in the literature both sets of in-
formation are recorded as separate entries in the
database and aweighting column added, based on the
number of papers describing each type of immune
response. Again we should make clear that we did
not conduct an exhaustive literature search for each
organism in this example.
Due to the limited number of records and infor-
mation in our database we conducted a further sim-
pliﬁcation with a grade given (on the basis of the
cytokine proﬁle) to indicate whether the disease was
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associated with up, down or no regulation of the Th1,
Th2, Th17 and T regulatory cell responses (Table 1).
Step 2: Deﬁning the IAG
Once a database has been produced it may be used to
deﬁne the immune activity groups. Our groupings
were deﬁned simply by establishing how many
unique proﬁles could be found in the dataset. In this
case we ﬁnd ﬁve distinct proﬁles which are char-
acterized in Table 2. Fig. 2 diagrammatically re-
presents the proposed relationships between our
deﬁned immune activity groups.
Step 3: Deﬁning the PFG
Once the immune activity groups have been estab-
lished the pathogen functional groups can also be
created. This step is a simple process, with each
pathogen being given two IAG scores as described
above. For our pathogens 12 distinct PFG were de-
ﬁned (Table 3). This may appear to be a large
number of groups to deal with but, as stated earlier,
each group is still centred on only the ﬁve immune
activity groups and their inﬂuences upon one another
are relatively simple to deﬁne and model. Of further
interest is the grouping of unrelated taxa in some of
these PFG. Measles and Giardia spp. both show
proﬁles in PFG 6, characterized by a Th1 response
with no T-regulatory involvement. Rotavirus and
Neisseria spp. have proﬁles in PFG 9, characterized
Table 1. Pathogen database example showing pathogen species or genus, taxa (B=bacteria, F=fungi,
H=helminth, P=protozoa, V=virus) of the pathogen, whether the immune proﬁle is representative of
ongoing disease (D – upper section) or of an infection which is being controlled (C – lower section), the
proposed functional groupmembership (see also Table 2) and the score for T cell responses (no or no recorded
response=0, up-regulated response=1, down-regulated response=x1) of each pathogen
Organsims Taxa
Disease/Control
Proﬁle
Functional
Group Th1 Th2 Th17 Treg
Aspergillus spp. F D 1 0 1 0 1
Ascaris suum H D 1 0 1 0 1
Schistosoma spp. H D 1 0 1 0 1
Trichinella spiralis H D 1 0 1 0 1
Leishmania spp. P D 1 0 1 0 1
Candida spp. F D 2 1 1 1 0
Giardia spp. P D 2 1 0 1 0
Malaria P D 2 1 0 0 0
Measles V D 2 1 1 1 0
Listeria spp. B D 3 1 0 1 1
Mycobacterium tuberculosis B D 3 1 0 1 1
Neisseria spp. B D 3 1 0 1 1
Trichuris spp. H D 3 1 x1 0 1
Rotavirus V D 3 1 x1 1 1
RSV V D 4 x1 1 0 1
Trichinella spiralis H C 1 0 1 0 1
Aspergillus spp. F C 2 1 0 1 0
Giardia spp. P C 2 1 0 0 0
Measles V C 2 1 1 1 0
RSV V C 2 1 0 0 0
Candida spp. F C 3 1 0 0 1
Malaria P C 3 1 x1 1 1
Neisseria spp. B C 3 1 0 1 1
Schistosoma spp. H C 3 1 1 0 1
Rotavirus V C 3 1 x1 0 1
Ascaris suum H C 4 x1 1 0 0
Trichuris spp. H C 4 x1 1 0 0
Leishmania spp. P C 5 1 1 0 x1
Listeria spp. B C 5 x1 0 0 x1
Mycobacterium tuberculosis B C 5 1 1 1 x1
Table 2. Deﬁning features of the proposed
immunological activity groups, using the T cell
proﬁles. Blank cells indicate that any response is
allowable. No response=0, an up-regulated
response=1 and a down-regulated response=x1
Functional
group Th1 Th2 Th17 Treg
1 0 1 1
2 1 0
3 1 1
4 x1 1 0
5 x1
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by a Th1 response but moderated by a T regulatory
cell response. Listeria spp. and Mycobacterium
tuberculosis show proﬁles in PFG 11, which for their
disease proﬁle show the same immune proﬁle as PFG
9 but for their control response are characterized by a
down-regulation of the T regulatory cell response.
Why do some PFG contain only one IAG?
In our deﬁned PFG, the IAG for the disease proﬁle
is sometimes the same as for the control proﬁle.
There are three possible explanations for this.
Firstly, organisms which show acute dynamics may
stimulate an immune response that is eﬀective at
clearing the disease and their chief strategy for sur-
vival is to reproduce and transmit rapidly before
the immune system has time to mount the eﬀective
response. Secondly, the pathogen may show acute
but recurrent dynamics, wherein the immune re-
sponse stimulated is eﬀective against a certain life-
stage of the pathogen, but the pathogen also has a
life-stage within the host which is resistant, dormant
or can sequester away from the immune components.
Similarly, where there is no or only short immune
memory, re-infection with the same species, can also
result in these acute dynamics. The latter two pos-
sibilities are not taken into account in our simple
examples, but could be incorporated in the full data-
base, for development of the IAG and PFG and the
subsequent model.
Step 4: Production of the functional group model
As we have shown, functional group models have
proven useful in determining likely changes in an
ecosystem given perturbations to that system and
model manipulations can be used to assess the best
solutions to ecosystem problems. Models are also
useful because multiple model manipulations can be
carried out without the need for expensive and
sometimes impractical experimentation. Creation of
a functional group model for pathogen ecosystems
would allow similar system engineering to be under-
taken and thus introduce a mechanism for more
eﬃcacious pathogen control and prediction of co-
infection consequences.
The model should contain the descriptors of
the PFG inﬂuences on the immune components (in
our example the T cells) and also the eﬀects of those
immune components upon the pathogen. To assess
the eﬀects of the immune components on the
pathogens we need to know whether the pathogen is
in the disease or clearance phase, in other words is
the immune response appropriate for controlling
the pathogen. As stated earlier, pathogens may move
between functional groups depending on stage of
infection. For simplicity in this example we choose
two pathogens for which their two IAG are the same
and for which there is published evidence of the
consequence of co-infection. We therefore consider
the example of a co-infection with the protozoan
Giardia lamblia and the helminth Trichinella spiralis.
(von Allmen et al. 2006), which the literature
suggests should lead to an increase in the number
of G. lamblia trophozoites if the infections are con-
current.
According to our example PFG classiﬁcation,
Trichinella spp. fall into PFG 1, with both IAG
scoring 1. This IAG is chieﬂy characterized by the
up-regulation of both Th2 and T regulatory cell re-
sponses. Giardia spp. are classiﬁed as PFG 6 in our
IAG – 1
IAG – 4 IAG – 2 IAG – 5
IAG – 3
Th2(+) Treg(+)
Th1(-) Th2(+)
Th17(0) Th1(+) Treg(0) Treg(-)
Th1(+) Treg(+)
Fig. 2. Hypothesised relationship between the immune
activity groups (IAG). Black arrows indicate
down-regulatory processes and white arrows indicate
up-regulatory processes. The thickness of the arrow
equates to the proposed strength of the action of one
group upon another. T regulatory mechanisms are
assumed to have down-stimulatory eﬀects on Th1
responses only.
Table 3. Pathogen functional group (PFG)
allocation, revealing 12 distinct functional groups
deﬁned by their ongoing disease (Disease) and
infection control (Control) immune activity group
(IAG) proﬁles
Organism Taxa Disease Control PFG
Trichinella spiralis H 1 1 1
Aspergillus spp. F 1 2 2
Schistosoma spp. H 1 3 3
Ascaris suum H 1 4 4
Leishmania spp. P 1 5 5
Measles V 2 2 6
Giardia spp. P 2 2 6
Malaria P 2 3 7
Candida spp. F 3 2 8
Rotavirus V 3 3 9
Neisseria spp. B 3 3 9
Trichuris spp. H 3 4 10
Listeria spp. B 3 5 11
Mycobacterium
tuberculosis
B 3 5 11
RSV V 4 2 12
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proposed system, with both IAG scoring 2. Immune
activity group 2 is characterized by an up-regulation
of the Th1 response and no evidence of any T regu-
latory activity.
A functional group simulation model was formed
in the statistical package, Mathematica (v6.0). The
model consisted of a series of diﬀerential equations
for describing the functional groups and their inter-
actions with the components of the immune re-
sponse. The functional group equations are deﬁned
below:
dF1=dt=a1  F1xb1  F1  eTh2 (1)
dF3=dt=a2  F3xb2  F3  eTh1 (2)
where Fi refers to the functional group number i ; ai is
the relative growth rate of the pathogen population in
functional group i; bi is the relative death rate of the
pathogen population in functional group i. Further
there are three immune parameters modelled, the
Th1 response, the Th2 response and the T regulatory
cell response (Tr).We assume that over the time span
of the model no immune decay occurs. The Th1 and
Th2 responses are assumed to have equivalent down-
regulatory eﬀects upon one another. Additionally,
the Tr response has a down-regulatory eﬀect on
the Th1 production which is ten-fold the level of the
direct eﬀects of Th1 and Th2 upon one another. The
formulae for these immune responses are below:
dTh1=dt=c1  F3  excrTrxc2Th2 (3)
dTh2=dt=c2  F1  exc1Th1 (4)
dTr=dt=cr  F1 (5)
Where ci is the stimulation rate of the immune re-
sponse for immune response i ; -cj is the moderator of
the down-regulatory eﬀect of the immune response
j upon immune component i.
Detailed descriptions of pathogen growth and
death rates are often absent from the literature.
There is usually suﬃcient data to describe the or-
ganisms qualitatively. For example, we can establish
from the literature that Trichinella spp. infections in
mice have a comparatively lower growth rate (within
the host) than Giardia spp. and that T. spiralis has
approximately similar temporal dynamics (14–20 day
infection) to the faster replicating G. lamblia,
(Gbakima, 1993; Gurish et al. 2004). A complete
list of the parameters used for the model is given in
Table 4. Parameter values were chosen to give model
outputs which, in the modelled single species infec-
tions, broadly represented the pathogen dynamics
described in the literature (Gbakima, 1993; Gurish
et al. 2004; von Allmen et al. 2006). The growth rate
of the T. spiralis infection (reproduction–death) was
adjusted to give the approximately 350 adult worms
at day 10 which was the peak of adult worm numbers
in the study of Gurish et al. (2004). The outputs
of the single and two species models may be seen in
Fig. 3. Themodel successfully predicts an increase in
G. lamblia trophozoites in the presence of T. spiralis.
Table 4. Parameter values for the model describing
the interaction between pathogen functional
groups 1 and 3
Parameter Value
a1 0.9
a2 2.8
b1 0.35
b2 1.2
c1 1.5E-5
c2 1.0E-3
cr 1.0E-3
xc1 0.1
xc2 0.1
xcr 1.0
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Fig. 3. Example pathogen functional group (PFG) model
simulations for the single and mixed infections of
functional group 1 (Trichinella spiralis.) and functional
group 6 (Giardia lamblia.). Panels (a) and (b) show the
model dynamics for the infections with PFG 1 and
PFG 6 respectively. Solid lines represent single species
infections and dashed lines represent the pathogen
dynamics in co-infection.
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It also suggests that the duration of infection
(calculated as days that the pathogen count is above
one) will increase. T. spiralis infection level is also
predicted to increase, although no increased duration
of infection is observed. However, the model
only succeeds qualitatively. In the experimental
system both the number of trophozoites and the
duration of the infection are much more severely
increased. Nevertheless, even a qualitative statement
about the eﬀects of co-infection could be useful
in a clinical setting. We re-emphasise that this
model is extremely simplistic and is only a demon-
stration of how such techniques might be usefully
employed.
It should also be noted that in previous work with
T. spiralis and G. lamblia, where the T. spiralis in-
fection was given prior to the G. lamblia, there was a
strong reduction in the number of G. lamblia tro-
phozoites. Our current model does not allow for the
complexity of time dependency in the immune re-
sponse. During the development of a model for
clinical use, any time dependency in the various IAG
would need to be incorporated.
Despite its quantitative shortcomings, even this
simple model, based on example functional groups
and derived from a very limited dataset, proves to be
a useful qualitative tool in predicting the outcome of
co-infection. Therefore, there should be little doubt
that a more detailed model, based around functional
groups, which are derived from a comprehensive
dataset, could prove equally useful in a clinical set-
ting.
Objective methods for deﬁning the IAG
Of course, the form of grouping we have used for our
example data is very subjective and ideally, especially
for larger datasets, some automated, objective
mechanism of grouping would be used. Although,
the formulation of such a mechanism is again beyond
the scope of this preliminary study, such tools do
exist. One option is the use of neural networks. In
particular, self-organising maps (SOM) have been
successfully used to classify organisms based upon a
set of traits (Park et al. 2004; Weller, Harris and
Ware, 2006). These networks may be unsupervised,
where no preliminary classiﬁcation is known, and
the SOM seeks to group data without this prior
knowledge, or they may be supervised, where a
classiﬁcation is already known and the model then
ﬁts new data to the established criteria. The un-
supervised SOM could be useful for initial immune
activity group classiﬁcation and the supervised SOM
could then be used to ﬁt novel organisms to this
classiﬁcation system.
Weller et al. (2006) successfully used unsupervised
SOM to classify dinoﬂagellate cysts based on image
data. Similarly, Park et al. (2004) used SOM in
conjunction with a second method called adaptive
resonance theory (ART) to successfully predict
Table 5. List of studies used to deﬁne the immunological (cytokine) responses for each organism in the
example database
Organism Studies
Trichinella spiralis (Rousseau et al. 1997; Onah and Wakelin, 1999; Vallance et al. 2000; Khan et al.
2001; Helmby and Grencis, 2002)
Aspergillus spp. (Allard et al. 2006; Stevens, 2006)
Measles (Karosi et al. 2006; Mikhailova et al. 2006; Tishon et al. 2006; Yanagi et al. 2006)
Giardia spp. (Singer and Nash, 2000; Bayraktar et al. 2005; Li et al. 2006)
RSV (Becker, 2006; Riﬀault et al. 2006; Stewart et al. 2006; Wang et al. 2006)
Schistosoma spp. (Baumgart et al. 2006; Cardoso et al. 2006; Coutinho et al. 2006; Dunne et al. 2006;
Ferrari et al. 2006; Perona-Wright et al. 2006; Reimert et al. 2006; Sousa-Pereira et al.
2006)
Malaria (Dekossodo and Grau, 1993; Seoh et al. 2003; Deshpande and Shastry, 2004;
Ramharter et al. 2004; Farouk et al. 2005; Furuta et al. 2006; John et al. 2006; Parekh
et al. 2006; Seixas and Ostler, 2005; Sharma et al. 2006)
Candida spp. (De Bernardis et al. 2006; Egusa et al. 2006; Kosonen et al. 2006)
Rotavirus (Jiang et al. 2003; Azevedo et al. 2006; VanCott et al. 2006; Xu et al. 2006)
Neisseria spp. (Fowler et al. 2006; Morales et al. 2006; Zarantonelli et al. 2006)
Ascaris suum (Deehan et al. 2002; Paterson et al. 2002; Souza et al. 2004; Dawson et al. 2005;
McConchie et al. 2006)
Trichuris spp. (Taylor et al. 2000; Liu et al. 2005; Parthasarathy and Mansﬁeld, 2005;
deSchoolmeester et al. 2006; Kringel et al. 2006)
Leishmania spp. (Roberts, 2005; Abolhassani and Darabi, 2006; Mukherjee et al. 2006; Mullen et al. 2006;
Pepe et al. 2006; Santiago et al. 2006)
Listeria spp. (Torres et al. 2005; D’Orazio et al. 2006; Foulds et al. 2006; Ozoren et al. 2006;
Popov et al. 2006)
Mycobacterium tuberculosis (Cooper et al. 1993; Feng et al. 2006; Loeuillet et al. 2006; Thom et al. 2006;
Warrender et al. 2006; Wieland et al. 2006)
Functional groups of pathogens 833
benthic macro-invertebrate group membership
under diﬀering water quality conditions. Further,
adapted SOM can be used on categorical data (Hsu,
2006), which is the most likely form of data available
for a pathogen/immunological database.
Step 5: Model validations
Once a suitable dataset has been collected, the
functional groups deﬁned and the model produced
there must be a phase of validation before the model
could be safely utilised in a clinical setting. At the
heart of the modelling approach is the assumption
that the functional groups and their predicted link-
ages are correct. Tests of this hypothesis could take
several forms. Firstly, the limited literature de-
scribing the consequences of particular co-infections
could be used as in the described example above. The
pathogens in these studies could be assigned to their
relevant functional groups and the predicted out-
come of the model could then be checked against the
experimental data in the relevant journal articles.
Additionally, the model could be used to predict the
outcomes of particular clinical co-infections (in-
cluding the consequence of speciﬁc treatments) and
these could be compared with the outcomes for those
patients. Finally, where speciﬁc gaps in knowledge
occur, e.g. where there is no literature or clinical data
against which to test particular functional group
combinations, laboratory experiments could be con-
ducted. At each stage of model validation, the func-
tional groups and, particularly, the linkages between
the groups could be reﬁned if errors were found.
CONCLUDING REMARKS
Once reﬁned, the ﬁnal model could be used to assess
the optimal control strategies for anygivennetwork of
co-infecting organisms. Perturbations of individual
and multiple functional groups could be undertaken
to mimic diﬀerent vaccine and chemotherapeutic
treatments and the eﬀects upon all groups and upon
the host (presuming a damage component is included
in the model) could then be assessed.
The signiﬁcance of the proposed simpliﬁcation
mechanismwould be in oﬀering the ﬁrst step towards
a generic and practical methodology for assessing
control strategies in multi-pathogen infections. No
such decision-support tool presently exists. While it
is likely that a ﬁnal model for clinical use would take
several years to develop, at each step along its pro-
duction path the process itself would undoubtedly
increase knowledge and understanding in the rapidly
growing ﬁeld of co-infection biology.
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